HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals
| Status: | Recruiting |
|---|---|
| Conditions: | Cervical Cancer, Cervical Cancer, Cancer, Women's Studies |
| Therapuetic Areas: | Oncology, Reproductive |
| Healthy: | No |
| Age Range: | 25 - 65 |
| Updated: | 6/8/2018 |
| Start Date: | May 12, 2018 |
| End Date: | May 1, 2019 |
| Contact: | Julia Seay, PhD |
| Email: | j.seay@med.miami.edu |
| Phone: | 704-575-3739 |
The proposed study will examine the implementation of a Human Papillomavirus (HPV)
self-sampling intervention for unscreened and under-screened transgender men and
transmasculine individuals living in South Florida. The study will enroll participants to
receive this cervical cancer screening intervention in community venues. The purpose of this
study is to pilot the self-sampler for feasibility and acceptability within this underserved
population.
self-sampling intervention for unscreened and under-screened transgender men and
transmasculine individuals living in South Florida. The study will enroll participants to
receive this cervical cancer screening intervention in community venues. The purpose of this
study is to pilot the self-sampler for feasibility and acceptability within this underserved
population.
Inclusion Criteria:
- Self-identify as transgender male or as transmasculine
- Assigned female sex at birth
- English speaking
- ages 25-65 years
- report not having had a pap smear in the last three years
- if age 30 and over, report not having a Pap smear/HPV co-test in the past 5 years
Exclusion Criteria:
- • Those who report having had a hysterectomy
- Those who report having history of cervical cancer
- Adults unable to consent
- Those who are pregnant
- Prisoners
We found this trial at
1
site
University of Miami A private research university with more than 15,000 students from around the...
Click here to add this to my saved trials
